iShares Neuroscience and Healthcare ETF Rating $25.47 +0.10 (+0.39%) (As of 12/20/2024 04:33 PM ET) Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatings iShares Neuroscience and Healthcare ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IBRN Aggregate RatingModerate Buy 2.83Holdings in IBRN have an aggregate rating of Moderate Buy based on 383 analyst ratings issued in the past year covering 41 companies (86.6% of the portfolio).IBRN Aggregate Price Target$25.47High Prediction$25.47Average Prediction$25.47Low Prediction$25.47Holdings in IBRN have an aggregate price target of $25.47 and a range of $25.47 to $25.47 covering 41 companies (86.6% of the portfolio).IBRN Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy24 Buy rating(s)Moderate Buy11 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce2 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares Neuroscience and Healthcare ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 41 IBRN Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.92%PTCTPTC Therapeutics$46.24+2.2%3.6564 of 5 stars2.47$54.08 16.9%15Analyst DowngradePositive News5.45%SRRKScholar Rock$44.78+6.4%3.9825 of 5 stars3.14$40.43 -9.7%7Positive NewsHigh Trading Volume4.72%BHVNBiohaven$36.26+2.6%3.7245 of 5 stars3.07$63.00 73.7%14Analyst ForecastHigh Trading Volume4.55%ALKSAlkermes$29.71-0.9%4.6622 of 5 stars2.58$35.42 19.2%12Positive NewsHigh Trading Volume4.47%ARGXargenx$623.82-0.4%3.0031 of 5 stars2.91$639.78 2.6%22Analyst ForecastShort Interest ↓Positive News4.47%ITCIIntra-Cellular Therapies$83.45-0.8%4.0584 of 5 stars2.85$97.23 16.5%134.32%CPRXCatalyst Pharmaceuticals$21.27-0.9%4.7487 of 5 stars3.00$31.14 46.4%7Positive News4.32%XENEXenon Pharmaceuticals$38.63-0.7%2.7929 of 5 stars3.11$56.00 45.0%9Insider TradeHigh Trading Volume4.18%ACADACADIA Pharmaceuticals$16.87+0.8%3.7059 of 5 stars2.63$25.60 51.7%16High Trading Volume4.14%NBIXNeurocrine Biosciences$135.42+0.3%4.8318 of 5 stars2.83$166.00 22.6%23Analyst ForecastInsider TradeHigh Trading Volume3.86%SRPTSarepta Therapeutics$118.97-0.4%4.8184 of 5 stars2.91$178.71 50.2%22Analyst ForecastPositive News3.76%SUPNSupernus Pharmaceuticals$35.43-1.0%2.1975 of 5 stars2.50$36.00 1.6%2High Trading Volume3.64%EWTXEdgewise Therapeutics$30.78-0.1%2.7186 of 5 stars3.00$43.17 40.2%6Analyst ForecastAnalyst Revision3.47%DYNDyne Therapeutics$23.99-1.3%3.1548 of 5 stars3.08$50.42 110.2%13Positive News3.05%BIIBBiogen$146.47-0.6%4.6279 of 5 stars2.45$242.68 65.7%29Analyst DowngradeHigh Trading Volume3.00%IARTIntegra LifeSciences$21.80+0.4%3.9846 of 5 stars1.75$23.00 5.5%82.19%PRAXPraxis Precision Medicines$76.52+5.1%2.3973 of 5 stars2.89$146.33 91.2%9Gap Down1.73%AVDLAvadel Pharmaceuticals$10.31+2.0%2.6801 of 5 stars3.00$24.43 136.9%7Positive News1.28%AVXLAnavex Life Sciences$8.63+1.9%3.3432 of 5 stars3.33$43.00 398.3%3High Trading Volume1.25%PRTAProthena$15.22-4.9%1.6022 of 5 stars2.71$52.29 243.5%7Analyst ForecastNews CoverageHigh Trading Volume1.18%AXGNAxoGen$15.64+5.3%0.9786 of 5 stars3.00$15.00 -4.1%4Positive NewsHigh Trading Volume0.94%DNTHDianthus Therapeutics$23.80+3.3%1.319 of 5 stars3.20$46.43 95.1%10Analyst ForecastNews Coverage0.92%ZVRAZevra Therapeutics$8.49-0.6%2.9122 of 5 stars3.13$21.00 147.3%8High Trading Volume0.89%TRDAEntrada Therapeutics$17.59+1.8%2.5972 of 5 stars3.25$25.67 45.9%4Gap DownHigh Trading Volume0.85%CAPRCapricor Therapeutics$13.07+1.3%3.2137 of 5 stars3.00$34.50 164.0%6Positive NewsGap DownHigh Trading Volume0.82%ANNXAnnexon$5.23+0.2%1.916 of 5 stars3.00$15.80 202.1%6Analyst ForecastNews CoverageGap Down0.77%SGMOSangamo Therapeutics$2.47+6.9%1.7507 of 5 stars2.75$7.00 183.4%4Analyst ForecastNews Coverage0.75%TSHATaysha Gene Therapies$1.853.6259 of 5 stars3.00$6.63 258.1%8High Trading Volume0.70%RAPPRapport Therapeutics$18.07+1.2%1.5135 of 5 stars3.00$35.00 93.7%3High Trading Volume0.60%CLPTClearPoint Neuro$15.55+6.1%0.4538 of 5 stars3.00$11.33 -27.1%3Positive News0.55%VYGRVoyager Therapeutics$5.75+1.1%4.6131 of 5 stars3.11$17.00 195.7%90.52%VNDAVanda Pharmaceuticals$4.78+3.2%3.9361 of 5 stars3.00$15.50 224.3%2Analyst ForecastNews Coverage0.47%NGNENeurogene$22.64+2.5%3.4772 of 5 stars3.11$60.83 168.7%9High Trading Volume0.45%LRMRLarimar Therapeutics$4.01+0.8%1.5648 of 5 stars3.09$20.43 409.4%11Analyst RevisionNews Coverage0.44%ABEOAbeona Therapeutics$5.70+1.2%3.5948 of 5 stars3.00$18.00 215.8%3Analyst Upgrade0.40%AMLXAmylyx Pharmaceuticals$4.05+2.3%4.2625 of 5 stars2.56$7.33 81.1%9Short Interest ↓News CoveragePositive News0.39%CTNMContineum Therapeutics$13.50+1.1%1.9552 of 5 stars3.20$29.25 116.7%5News CoverageHigh Trading Volume0.32%SLDBSolid Biosciences$4.16+3.7%3.668 of 5 stars3.33$15.22 265.9%12High Trading Volume0.30%ALECAlector$1.86+4.5%4.2778 of 5 stars2.14$3.75 101.6%7Analyst DowngradeHigh Trading Volume0.29%PEPGPepGen$3.63-11.2%2.1218 of 5 stars2.33$13.67 276.5%3Analyst RevisionNews CoverageHigh Trading Volume0.28%NVRONevro$3.79+5.6%2.1486 of 5 stars1.77$6.30 66.2%13Analyst Forecast This page (NYSEARCA:IBRN) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Neuroscience and Healthcare ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Neuroscience and Healthcare ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IBRN Stock Alerts